The European Commission validates 5 applications of CBD Novel Food – Newsweed

Novel Food CBD en Europe

Fears that the European Commission (EC) could once again change its position on the status of CBD have allayed after validating its first Novel Food applications for natural cannabis extracts. Thus, at least five companies have been informed by the EC that their CBD-related Novel Food dossiers have reached one of the final stages of the Novel Food process. The companies – CBDepot, based in the Czech Republic, PharmaHemp, based in Slovenia, the Swiss company Linnea, the French company Spectrums Europe and the British branch of Brains Bioceutical – have been notified and their contact details have been published on the portal Novel Food. The EC would not confirm whether any other imminent additions were planned. He only confirmed that he had validated Novel Food’s claims from “several companies.” A two-year delay This breakthrough was welcomed by the industry as great news, as many of the 130 EC applications for new food authorizations have been pending for more than two years, raising many concerns for this delay. Some of these concerns stemmed from the International Narcotics Control Board’s determination that all parts of cannabis pants are subject to international drug laws. This followed the EC’s change of position in July 2020 when it wanted to consider CBD as a narcotic, a decision it reversed a few months later following the KanaVape decision of the Court of Justice of the European Union (CJEU). In December 2020, the EC stated that it is resuming the CBD Novel Food process, and almost 14 months later, these CBD validations were hosted by one of the successful applicants Boris Baňas, Founder and Sales Director of CBDepot. He told BusinessCann: “This is an important milestone for the industry. Finally, after more than a year, the ECJ officially recognized the ECJ’s decision in the KanaVape case. “The validation of herbal applications involves that these extracts do not infringe the European Commission’s definition of food, confirming that it no longer considers CBD to be a narcotic. “The EC has finally made it official that hemp extracts with a negligible THC content do not fall under the United Nations Single Convention on Narcotic Drugs. This is despite several UN agencies, such as the INCB, still claiming otherwise. Step next after validation With validation completed, the applications in question will be examined by the European Food Safety Authority (EFSA). The latter will issue its scientific opinion “within nine months from the date of reception, noting, however, that extensions are possible if additional data is requested,” an EC official told BusinessCann. The official continues: “Following the publication of the EFSA opinion, and in the event of a favorable outcome, the Commission has seven months to present to the permanent committee (represented by the Member States) a draft act authorizing its commercialization. . The draft act envisages not only the placing on the market of the new food, but also the update of the Union list (of novel foods). He adds that if “EFSA’s opinion is not favorable or for any other legitimate reason, the Commission can end the authorization procedure”.
#European #Commission #validates #applications #CBD #Food #Newsweed


Please enter your comment!
Please enter your name here